- Record: found
- Abstract: not found
- Article: not found
LONG‐TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT FOR PATIENTS WITH MALT LYMPHOMA (MALT‐2008‐01).
A Salar, E Domingo-Domenech, C. Panizo, C Nicolas, J. Bargay, A Muntanola, M CANALES, J Bello, J SANCHO, J. TOMAS, M RODRÍGUEZ, F.J. Peñalver, L Palomera, C Grande, J.J. Sanchez‐Blanco, R. Arranz, E. CONDE, M. GARCIA, J.F. Garcia, D CABALLERO, C MONTALBÁN
2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Comments
Comment on this article
scite_